
A new Emory University study sheds light on the relationship between mental and cardiovascular health.

A new Emory University study sheds light on the relationship between mental and cardiovascular health.

How cardiovascular experts have been communicating with international colleagues to inform local care response.

A study of 416 hospitalized patients indicates 19.7% suffered cardiac injury, which was also associated with increased ventilation and mortality.

A discussion on a study from ACC.20 examining use of a novel genetic risk score to predict VTE in patients with cardiometabolic disease.

Digital tools can be leveraged to help treat more patients remotely.

The Mount Sinai expert and ACC late-breaking presentation panelist highlights her most anticipated trial data and discussions in the upcoming meeting.

Surgical intervention leads to a bigger reduction in pain intensity compared to a more conservative approach.

In a new study, investigators discover 7-8 hours as the optimal sleep duration for reducing the risk of strokes and heart disease.

What's known about at-risk cardiometabolic patient care during the pandemic.

It is essential to immediately roll out interventions to promote the well-being of women, nurses, and frontline workers exposed to COVID-19.

A new review from investigators at Columbia University details topics from common comorbidities to potential treatments.

While the opioid epidemic has had a devastating impact on American families, there is some hope that the future is bright.

A Keck Medicine expert explains how the California-based institution has pooled resources and personnel during their pandemic response.

Results of a study show the efficacy of an artificial intelligence chatbot for patients with asthma and pregnant women.

How will heart valve options refine and progress over the coming year?

Lisa Stein Gold, MD, of Henry Ford Hospital discusses promising phase 2 data for a new PDE4 inhibitor.

The document, which includes 11 clinical competencies for NPs and PAs, is the first of its kind from the American College of Cardiology.

In the phase 2 PIONEER trial, patients taking avapritinib self-reported improvements in quality of life.

Providers should consider flu in their diagnoses of patients who present at the hospital with less recognized manifestations.

How coronavirus spread has affected a New York institution's invasive cardiology department.

New expanded analysis from the IMPACT trial shows FF/UMEC/VI's benefit versus dual inhaler therapies.

The author of the first systematic evaluation of commissural alignment in TAVR shares his team's findings.

About 1 in every 20 adult Americans now reguarly uses vaping and e-cigarette products.

The vaccine is safe and effective in preventing pneumococcal disease and pneumonia.

Technology, data, and community partnerships can help improve the overall health of patients with chronic health conditions.